Science: Vaccines/AIDS/Mars Pathfinder

Theoretically ...

Monday 13 October 1997 18:02 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

We had hoped for a vaccine effective against several diseases - and reported as much here on 5 August, about the trials by Stanford Rook of a TB vaccine. But the results are out, and the Phase III clinical trial in South Africa was a failure: SRL 172 showed no improvement on DOTS, the standard drug treatment (though as that is 95 per cent effective, maybe that's not surprising). Ever hopeful, Stanford Rook is waiting for the results from a Phase III trial against malignant melanoma (skin cancer). Present best treatments only manage 15 per cent success.

Confusion in the search for genetic resistance to AIDS: Earlier this year a team at the National Cancer Institute reported that a mutation in the CCR2 gene could slow down AIDS in HIV-positive people by two to four years. But a team at the Walter Reed Army Institute of Research in Rockville, Maryland, examined 400 people and found no difference. However, the NCI team reckons the new team couldn't find the effect because they didn't pinpoint the time of HIV infection.

Mars Pathfinder is finally talking to its owners. Recently the team at the Jet Propulsion Laboratory in Pasadena got their first signal after nine days in which the system fell into a mistiming problem. As the sun rose, several instruments turned on simultaneously before the solar panels were fully powered. The resulting drain caused a power dip, and so shut down the computer. That, in turn, threw off the computer's clock. And so it went on. Meanwhile the Sojourner rover drove itself in a slow circle around the lander, using a built-in program. Still, both have far outlived their primary missions - seven days for the rover and 30 for the lander. They're now pushing 90 days.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in